Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,821 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chronic myeloid leukemia following treatment for bilateral retinoblastoma.
Kamitori T, Umeda K, Tasaka K, Ogata H, Mikami T, Kato I, Hiramatsu H, Kondo T, Adachi S. Kamitori T, et al. Among authors: ogata h. Pediatr Blood Cancer. 2018 Sep;65(9):e27107. doi: 10.1002/pbc.27107. Epub 2018 May 4. Pediatr Blood Cancer. 2018. PMID: 29727044 Free article. No abstract available.
Intracranial Growing Teratoma Syndrome With Intraventricular Lipid Accumulation.
Tasaka K, Umeda K, Kamitori T, Ogata H, Mikami T, Saida S, Kato I, Hiramatsu H, Arakawa Y, Uto M, Mizowaki T, Yoshizawa A, Adachi S, Takita J. Tasaka K, et al. Among authors: ogata h. J Pediatr Hematol Oncol. 2021 May 1;43(4):e505-e507. doi: 10.1097/MPH.0000000000001905. J Pediatr Hematol Oncol. 2021. PMID: 32769571
Improvement of Bone Marrow Necrosis by Tyrosine Kinase Inhibitor Substitution in a Pediatric Patient With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
Mikami T, Kato I, Oiki N, Okamoto S, Kamitori T, Tasaka K, Ogata H, Tanaka K, Umeda K, Hiramatsu H, Okamoto T, Adachi S, Takita J. Mikami T, et al. Among authors: ogata h. J Pediatr Hematol Oncol. 2022 Mar 1;44(2):e539-e542. doi: 10.1097/MPH.0000000000002157. J Pediatr Hematol Oncol. 2022. PMID: 33843813
CD146 is a potential immunotarget for neuroblastoma.
Obu S, Umeda K, Ueno H, Sonoda M, Tasaka K, Ogata H, Kouzuki K, Nodomi S, Saida S, Kato I, Hiramatsu H, Okamoto T, Ogawa E, Okajima H, Morita K, Kamikubo Y, Kawaguchi K, Watanabe K, Iwafuchi H, Yagyu S, Iehara T, Hosoi H, Nakahata T, Adachi S, Uemoto S, Heike T, Takita J. Obu S, et al. Among authors: ogata h. Cancer Sci. 2021 Nov;112(11):4617-4626. doi: 10.1111/cas.15124. Epub 2021 Sep 30. Cancer Sci. 2021. PMID: 34464480 Free PMC article.
Clinical Outcomes of Patients With Osteosarcoma Experiencing Relapse or Progression: A Single-institute Experience.
Umeda K, Sakamoto A, Noguchi T, Uchihara Y, Kobushi H, Akazawa R, Ogata H, Saida S, Kato I, Hiramatsu H, Uto M, Mizowaki T, Haga H, Date H, Okamoto T, Watanabe K, Adachi S, Toguchida J, Matsuda S, Takita J. Umeda K, et al. Among authors: ogata h. J Pediatr Hematol Oncol. 2023 Apr 1;45(3):e356-e362. doi: 10.1097/MPH.0000000000002521. Epub 2022 Aug 10. J Pediatr Hematol Oncol. 2023. PMID: 35973000
1,821 results